Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
Primary immunodeficiency diseases (PIDs) are a group of rare inherited disorders affecting the immune system that can be conventionally treated with allogeneic hematopoietic stem cell transplantation and with experimental autologous gene therapy. With both approaches still facing important challenge...
Main Authors: | Asma Naseem, Zohar Steinberg, Alessia Cavazza |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.966084/full |
Similar Items
-
Fatal Cytomegalovirus Gastrointestinal Disease in an Infant with Wiskott-Aldrich Syndrome
by: Kuan-Ying Huang, et al.
Published: (2008-01-01) -
Autoimmunity in Wiskott-Aldrich Syndrome: an unsolved enigma
by: Marco eCatucci, et al.
Published: (2012-07-01) -
Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome
by: Melissa Pille, et al.
Published: (2024-03-01) -
The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation
by: Melissa Pille, et al.
Published: (2023-06-01) -
Analysis of clinical and molecular genetic characteristics of Wiskott-Aldrich syndrome and X-linked thrombocytopenia
by: Doina TURCAN, et al.
Published: (2021-06-01)